Coronary sinus size and ischemia improvement after reducer implantation; "one size to fit them all?"

cardiac magnetic resonance coronary sinus reducer myocardial ischemia non-responders refractory angina

Journal

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions
ISSN: 1522-726X
Titre abrégé: Catheter Cardiovasc Interv
Pays: United States
ID NLM: 100884139

Informations de publication

Date de publication:
09 2021
Historique:
revised: 29 01 2021
received: 07 04 2020
accepted: 19 03 2021
pubmed: 15 4 2021
medline: 21 10 2021
entrez: 14 4 2021
Statut: ppublish

Résumé

Coronary sinus (CS) reducer implantation is associated with symptomatic relief of patients with refractory angina. However, 15% to 30% of the patients do not respond to this treatment. Aim if this study was to evaluate the effect of CS size in the effectiveness of the device. Prior to device implantation and at 4-month resting ventricular function was assessed by stress cardiac magnetic resonance. Ischemia was assessed by the myocardial perfusion reserve index (MPRI). Fifteen patients (66 ± 10 years) underwent successful CS Reducer implantation, with improvements in angina class and exercise tolerance. Patients with a smaller CS size (<5.8 mm) presented a significantly higher percentage increase in MPRI (63 ± 51 vs 9 ± 30%, P = .03) and a higher reduction in left ventricle end-diastolic volumes. Greater benefits, in terms of ischemia improvement, after CS Reducer implantation were seen in patients with smaller CS sizes, suggesting a potential mechanism underlying the observed rates of reducer non-responsiveness.

Identifiants

pubmed: 33851771
doi: 10.1002/ccd.29699
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

E365-E369

Informations de copyright

© 2021 Wiley Periodicals LLC.

Références

Verheye S, Jolicoeur EM, Behan MW, et al. Efficacy of a device to narrow the coronary sinus in refractory angina. N Engl J Med. 2015;372(6):519-527.
Giannini F, Baldetti L, Konigstein M, et al. Safety and efficacy of the reducer: a multi-center clinical registry - reduce study. Int J Cardiol. 2018;269:40-44.
D'Amico G, Giannini F, Massussi M, et al. Usefulness of coronary sinus reducer implantation for the treatment of chronic refractory angina pectoris. Am J Cardiol. 2021;139:22-27.
Zivelonghi C, Verheye S, Timmers L, et al. Efficacy of coronary sinus reducer in patients with non-revascularized chronic total occlusions. Am J Cardiol. 2020;126:1-7.
Verheye S, Agostoni P, Giannini F, et al. Coronary sinus narrowing for the treatment of refractory angina a multi-center prospective open-label clinical study (the REDUCER-I study). EuroIntervention. 2020:EIJ-D-20-00873. https://doi.org/10.4244/EIJ-D-20-00873. [Epub ahead of print].
Giannini F, Palmisano A, Baldetti L, et al. Patterns of regional myocardial perfusion following coronary sinus reducer implantation. Circ Cardiovasc Imaging. 2019;12(9):e009148.
Hussain ST, Paul M, Plein S, et al. Design and rationale of the MR-INFORM study: stress perfusion cardiovascular magnetic resonance imaging to guide the management of patients with stable coronary artery disease. J Cardiovasc Magn Reson. 2012;14:65.
Kramer CM, Barkhausen J, Flamm SD, Kim RJ, Nagel E. Society for Cardiovascular Magnetic Resonance Board of trustees task force on standardized P. Standardized cardiovascular magnetic resonance imaging (CMR) protocols, society for cardiovascular magnetic resonance: board of trustees task force on standardized protocols. J Cardiovasc Magn Reson. 2008;10:35.
Zivelonghi C, Vermeersch G, Verheye S, Agostoni P. Incomplete coronary sinus reducer endothelialization as potential mechanism of clinical failure. Catheter Cardiovasc Interv. 2019;94(1):120-122.
Giannini F, Tzanis G, Banai S, Colombo A. Incomplete coronary sinus reducer endothelialization as potential mechanism of clinical failure. Catheter Cardiovasc Interv. 2020;96(4):E493-E494.
Baldetti L, Colombo A, Banai S, et al. Coronary sinus reducer non-responders: insights and perspectives. EuroIntervention. 2018;13(14):1667-1669.
D'Amico G, Massussi M, Fraccaro C, Tarantini G. Coronary sinus reducer implantation in the middle cardiac vein for the treatment of refractory angina. Catheter Cardiovasc Interv. 2020;95(4):718-721.

Auteurs

Georgios Tzanis (G)

Unit of Cardiovascular Interventions, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Interventional Cardiology Department, Henry Dunant Hospital Center, Athens, Greece.

Arif A Khokhar (AA)

Interventional Cardiology Unit, GVM Care & Research Maria Cecilia Hospital, Cotignola, Italy.

Francesco Ponticelli (F)

Unit of Cardiovascular Interventions, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Interventional Cardiology Unit, GVM Care & Research Maria Cecilia Hospital, Cotignola, Italy.

Guglielmo Gallone (G)

Unit of Cardiovascular Interventions, IRCCS San Raffaele Scientific Institute, Milan, Italy.

Anna Palmisano (A)

Department of Radiology and Experimental Imaging Centre, IRCCS San Raffaele Scientific Institute, Milan, Italy.

Antonio Esposito (A)

Department of Radiology and Experimental Imaging Centre, IRCCS San Raffaele Scientific Institute, Milan, Italy.

Alessandro Beneduce (A)

Unit of Cardiovascular Interventions, IRCCS San Raffaele Scientific Institute, Milan, Italy.

Stefano Guarracini (S)

Department of Cardiology, Pierangeli Clinic, Pescara, Italy.

Antonio Colombo (A)

Interventional Cardiology Unit, GVM Care & Research Maria Cecilia Hospital, Cotignola, Italy.

Francesco Giannini (F)

Interventional Cardiology Unit, GVM Care & Research Maria Cecilia Hospital, Cotignola, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH